Skip to main content

Table 1 Characteristics of patients with methicillin-resistant Staphylococcus aureus eligible for decolonization between January 2006 and June 2010 (n = 442)

From: Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice

 

Proportion of patients

 
 

Patients treated

Patients not treated

P

(n = 268)

(n = 174)

 

Sex

Male 142 (53)

104 (60)

.160

 

Female 126 (47)

70 (40)

 

Age, mean, years ± SD

69.09 ± 16.52

69 ± 17.26

.9

Length of hospital stay mean, years ± SD

48.54 ± 35.71

36.91 ± 32.99

<.001

Type of MRSA colonization

   

 Nosocomial

107 (39.9)

88 (50)

.04

Site of colonization

   

 Nose

147 (55)

53 (26.5)

<.001

 Throat

115 (43)

43 (25)

<.001

 Perineum

116 (43)

39 (25)

<.001

 Others

109 (41)

146 (84)

<.001

 Wound

85 (31.7)

46 (26.4)

.2

Number of colonized sites

   

 Mean, no ± SD

1.8 ± 1

1.6 ± 0.94

.03

 ≥2sites

128 (47.8)

64 (36.8)

.02

Comorbidity (underlying condition)

   

 Immunosuppressive therapy

36 (13.4)

39 (52)

.01

 Diabetes

71 (65)

38 (35)

.26

 Urine catheter

14 (5.2)

6 (3.4)

.48

 Dialysis

11 (4.1)

4 (2.3)

.30

 CVC

9 (3.3)

10 (5.7)

.22

 COPD

31 (11.5)

33 (18.9)

.003

  1. Note: data are no (%) of patients